Lexicon Pharmaceuticals LXRX Income taxes at U.S. statutory rate of 21%
Income taxes at U.S. statutory rate of 21% at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.
The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's income taxes at u.s. statutory rate of 21%.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's income taxes at U.S. statutory rate of 21%?
- Lexicon Pharmaceuticals (LXRX) reported income taxes at U.S. statutory rate of 21% of 21% in Q4 2025.
- What does income taxes at U.S. statutory rate of 21% mean?
- The theoretical income tax expense or benefit derived by applying the standard U.S. federal statutory corporate tax rate to the company's pre-tax earnings or losses. It provides a benchmark for evaluating the impact of tax planning and regulatory adjustments on the company's actual tax burden.